High Purity Smart Drugs Rivastigmine Tartrate/nootropic@ycgmp.com

본문 바로가기


Home > Product > High Purity Smart Drugs Rivastigmine Tartrate/nootropic@ycgmp.com
Selling leads
High Purity Smart Drugs Rivastigmine Tartrate/nootropic@ycgmp.com
Posting date : May 20, 2017
Membership
Free Member Scince May 19, 2017
FOB Price
$1
Min. Order Quantity
5g
Supply Abillity
500kg/mongth
Port
HK/Shanghai
Payment Terms
T/T Bank wire transfer,Western Union,MoneyGram,Bitcoin
Package
discreet package for delivery guarantee
Keyword :
Category
Contact
Cindy Lee
Selling Leads Detail
Company Info
 
Quick Detail
Place of Origin
China [CN]
Brand Name
Biopharmchem
Model Number
CAS: 129101-54-8
HS-CODE
-
Package & Delivery Lead Time
Package
discreet package for delivery guarantee
Delivery Lead Time
5-7 working days
Detailed Description
High Purity Smart Drugs Rivastigmine Tartrate/nootropic@ycgmp.com
 
Product Name: Rivastigmine Tartrate
Alias: Rivastigmine-d6 tartarate
CAS: 129101-54-8
MF: C18H28N2O8
MW: 400.4235
Purity: 99%
MP: 123-125°C
BP: 316.2°C at 760 mmHg
FP: 145°C
Grade: Pharmaceutical Grade
Appearance: White Powder
 
Rivastigmine Tartrate is a parasympathomimetic or cholinergic agent for the treatment of mild to moderate dementia of the Alzheimer's type and dementia due to Parkinson's disease. The drug can be administered orally or via a transdermal patch; the latter form reduces the prevalence of side effects, which typically include nausea and vomiting.
 
Pharmacological Effects
 
Rivastigmine Tartrate is rivastigmine Alzheimer's disease drugs, rivastigmine is physostigmine derivative by Novartis for the first time successfully developed the trade name Exelon (exelon), a molecule with there carbamate structure, is a kind of amino acid of selective cerebral cholinesterase inhibitor, can also inhibit the acetylcholinesterase and butyrylcholinesterase, cholinergic neurons by delaying the release of acetylcholine degradation and energy promoting cholinergic nerve conduction, can improve cognitive function disorders mediated by cholinergic, thereby improving the cognitive function of Alzheimer's disease patients.
 
Rivastigmine Tartrate plasma protein binding is weak, easily through the blood-brain barrier, which has a high degree of brain selectivity. It not only selectively acts on the most easily affected cerebral cortex and hippocampus, but also preferentially inhibits the dominant subtype of AChE in the brain, resulting in a reduction in the efficacy of peripheral cholinergic side effects. Rivastigmine in vivo half-life is short and long duration of action. Unlike tacrine, this product in the hippocampus and cortex of G1 enzyme inhibitory effect is stronger. Clinic for the treatment of mild to moderate Alzheimer-type dementia, or Alzheimer's disease can be suspected Alzheimer's disease clinically.
 
Dosage
 
The dosage of Exelon to treat Alzheimer's Disease is 6-12 mg/day, given twice-a-day. The dose to treat Parkinson's Disease is 3-12 mg/day, given twice-a-day. Exelon may interact with atropine, belladonna, clidinium, dicyclomine, glycopyrrolate, hyoscyamine, mepenzolate, methantheline, methscopolamine, propantheline, or scopolamine. Tell your doctor all medications you are taking. During pregnancy, this medication should be used only when prescribed by a doctor. It is unknown if this medication passes into breast milk. Consult your doctor before breastfeeding.

ECROBOT CO., Ltd, Business Registration Number : 220-88-71747, CEO J.W.Park, TEL : +82-2-552-7676, E-mail : E-mail : Contact us
Address : (Hwanghwa B/D 11F, Yeoksam-dong)320, Gangnam-daero, Gangnam-gu, Seoul, South Korea
About Us Privacy Policy Terms of use Copyright © 2000-2024 ECROBOT.COM. All rights reserved.
Top